An enzyme-linked immunosorbent assay was developed for measuring immunoglobulin G anti-diphtheric toxin antibodies in human serum. The assay was done in plastic plates coated with purified diphtheric toxoid. Since a straight-line relationship was found between logs of extinction values and of antibody concentrations, with a very constant slope, serum titers could be expressed as log1o of the serum dilution corresponding to a definite optical density, such as 0. In this paper we present our results for the development and standardization of an ELISA for immunoglobulin G antibodies against diphtheric toxin in human serum and for establishing correspondence between ELISA titers and biologically determined antitoxin units.
purposes.
Diphtheria is still a serious problem in many underdeveloped countries, with significant morbidity rates (8) . Although the immunization program for children in Brazil follows international recommendations (7) , high diphtheria morbidity rates still occur for children under 10 years of age (1, 2) . For evaluation of immunization procedures and the vaccine itself, antibody levels against diphtheric toxin are useful to show the immune status of a population. However, the biological assay of anti-diphtheric toxin antibodies in human serum is not practical for seroepidemiological purposes, regardless of its sensitivity and reproducibility. The hemagglutination test with sensitized erythrocytes with diphtheria toxin or toxoid is easier to perform and of low cost; however, the assay is only semiquantitative, and titers are reported in steps of serum dilutions at intervals. More precise results might be obtained with an enzyme-linked immunosorbent assay (ELISA) that would define titers over a continuous range. In this paper we present our results for the development and standardization of an ELISA for immunoglobulin G antibodies against diphtheric toxin in human serum and for establishing correspondence between ELISA titers and biologically determined antitoxin units.
MATERIALS AND METHODS
Human sera. Venous blood was collected from first-grade school children 6 to 9 years old. Detailed registers on the doses of diphtheric vaccine were available. Samples were collected before a new dose of diphtheric vaccine and 30 to 60 days after (manuscript in preparation). Serum separated from clotted blood was stored at -20°C for a few days until tested.
Biological assay. Anti-diphtheric toxin antibodies were titrated by the rabbit intradermic test ELISA. Polystyrene plates with U-shaped wells (Interlab, Sao Paulo, Brazil) were coated with purified diphtheric toxoid (2,500 Lf/ml; Connaught Laboratories, Ontario, Canada). To prepare the plates the toxoid was diluted in 0.06 M sodium carbonate buffer (pH 9.6), and 200-pl volumes were added to the wells and left overnight at 4°C. The following morning the plates were emptied and drained over filter paper, filled with 2% gelatin in carbonate buffer, and incubated for 2 h at 37°C. After being washed three times with PBST (0.15 M NaCl, 0.01 M phosphates [pH 7.2] , 0.05% Tween 20), the plates were drained and used the same day.
For the test, 200-pAl volumes of serum dilutions in PBST were added to the wells of sensitized plates, incubated at 37°C for 60 min, and washed three times in PBST. Two hundred microliters of peroxidase anti-human immunoglobulin G ry-chain-specific conjugate (prepared by the method of Wilson and Nakane [10] ) diluted in PBST was added to each well, followed by incubation at 37°C for 60 min and washing of the plates. The plates were then left at room temperature with 200-pl volumes of a chromogen solution ( To determine the optimal antigen concentration for high sensitivity and low background, the plates were coated with serial twofold dilutions of diphtheric toxoid starting at 1:25. Best results were obtained for the 1:400 antigen dilution. For maximal activity, the conjugate could be used at 1:2,500. RESULTS Serum titrations. When serum samples were assayed in twofold dilutions starting from 1:20, straight lines were obtained by plotting logarithms of optical densities and serum dilutions between extinction values of 0.2 and 1.8. When comparing such dilution curves from a series of serum samples, very similar slopes were seen (Fig. 1) , for which a value of 0.73 was found to express the relationship between respective increases in log extinction and log dilution.
Serum titers were expressed as log1o of the serum dilution, corresponding to an optical density of 0.5, which was chosen as a definite point midway in the straight part of the curve. In this way titers could be determined from one optical density value falling within this section of the curve, according to equation A: T = log D + (log E -log 0.5)/0.73, with E being the extinction value observed for serum dilution D. Usually two serum dilutions were tested, and the titer was determined for each optical density between the extreme values of 0.2 and 1.8, a medium value being taken as the serum titer. In this case the titer could be alternatively determined according to equation B: T = log D, + (log El -log 0.5) (log D2-log Dl)I(log El -log E2), with El and E2 being the extinction values for dilutions D, and D2. No significant differences could be found between the titers determined by both procedures. Table 1 shows the results for 22 serum samples, with the t test indicating the differences as not significant (t = 0.0257).
To avoid the influence on titers of daily variations in test Thus, correspondence between ELISA titers and antitoxin units was determined by fitting the best regression equation between values from 112 serum samples titrated-in both tests and taking the antitoxin units as a reference. We established that the 2.38 ELISA titer correlated to an antitoxin titer of 0.01 U, which is considered as the minimal protective level. For these cutoff titers 90% agreement was found between both assays in discriminating protected from nonprotected individuals, the correspondence being expressed also by the high copositivity and conegativity indices of the ELISA as they referred to the biological assay. Antibodies detected by both techniques may not be the same. Perhaps better agreement between both assays could result from performing the ELISA with a toxoid antigenic fraction that might be more closely related to protective antibodies. Otherwise, observed differences may just be the expression of poorer reproducibility of the biological assay, the results of which could be only a more or less accurate approximation of the unknown real protection values.
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